Kangstem Biotech Co., Ltd. (KOSDAQ:217730)
South Korea
· Delayed Price · Currency is KRW 2,215.00
+205.00 (10.20%)
At close: Mar 9, 2026
Kangstem Biotech Revenue
Kangstem Biotech had revenue of 783.33M KRW in the quarter ending September 30, 2024, a decrease of -39.10%. This brings the company's revenue in the last twelve months to 12.77B, up 30.25% year-over-year. In the year 2023, Kangstem Biotech had annual revenue of 12.70B, down -22.06%.
Revenue (ttm)
12.77B
Revenue Growth
+30.25%
P/S Ratio
16.31
Revenue / Employee
131.70M
Employees
97
Market Cap
208.33B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ensol Biosciences | 537.46M |
| QuadMedicine | 13.11B |
| TiumBio | 9.32B |
| Prestige Biologics | 19.24B |
| ISU Abxis | 66.39B |
| Genome & Company | 25.95B |
| ABION | 1.03B |
| Bio Solution | 8.27B |